Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PACAP in immunity and inflammation.

Mario Delgado1, Catalina Abad, Cartmen Martinez

  • 1Department of Cell Biology, School of Biology, Complutense University, Madrid 28040, Spain. mdelgado@ipb.csic.es

Annals of the New York Academy of Sciences
|June 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic mediators in human osteoarthritis.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Osteoprotective effects of the neuropeptide VIP: insights from triple cultures of human osteocytes, osteoblasts, and osteoclasts.

Translational research : the journal of laboratory and clinical medicine·2026
Same author

[Pathophysiology of myositis: inflammation, oxidative stress and mitochondrial dysfunction].

Medecine sciences : M/S·2025
Same author

Preclinical efficacy of adipose-derived cell therapies for the treatment of myositis.

Stem cells translational medicine·2025
Same author

Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.

Scientific reports·2024
Same author

IFNγ causes mitochondrial dysfunction and oxidative stress in myositis.

Nature communications·2024

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a potent anti-inflammatory neuropeptide. PACAP shows promise for treating inflammatory and autoimmune diseases like septic shock and arthritis.

Area of Science:

  • Immunology
  • Neuroendocrinology
  • Molecular Biology

Background:

  • Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with diverse immunological functions.
  • PACAP regulates immune homeostasis via receptors on immunocompetent cells.
  • PACAP is recognized as a potent anti-inflammatory agent.

Purpose of the Study:

  • To investigate the anti-inflammatory and immunomodulatory roles of PACAP.
  • To explore PACAP's potential in managing inflammatory and autoimmune conditions.

Main Methods:

  • Analysis of PACAP's effects on inflammatory mediators.
  • Assessment of PACAP's influence on T-helper cell differentiation (Th1/Th2).
  • Evaluation of PACAP in disease models such as septic shock and arthritis.

Related Experiment Videos

Main Results:

  • PACAP prevents mortality in septic shock by modulating inflammatory responses.
  • PACAP downregulates inflammatory and autoimmune components in arthritis.
  • PACAP influences the shift from Th1 to Th2 immune responses by regulating costimulatory molecules.

Conclusions:

  • PACAP demonstrates significant therapeutic potential as an anti-inflammatory and immunomodulatory factor.
  • PACAP and its analogs are promising candidates for treating acute and chronic inflammatory and autoimmune diseases.
  • Potential applications include septic shock, arthritis, multiple sclerosis, Crohn's disease, and autoimmune diabetes.